Original Research
Accepted on 28 Nov 2025
Yiqi Yangyin Huoxue Tongluo prescription ameliorates inflammatory factors in patients with stage III–IV diabetic nephropathy
in Clinical Diabetes
Original Research
Accepted on 28 Nov 2025
in Clinical Diabetes
Systematic Review
Accepted on 28 Nov 2025
in Clinical Nutrition
Original Research
Accepted on 28 Nov 2025
in Psychopathology
Correction
Accepted on 28 Nov 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 28 Nov 2025
in Data Analytics for Social Impact
Original Research
Accepted on 28 Nov 2025
in Language, Culture and Diversity
Review
Accepted on 28 Nov 2025
in Aging and Public Health
Perspective
Accepted on 28 Nov 2025
in Leadership in Education
Original Research
Accepted on 28 Nov 2025
in Antibiotic Resistance and New Antimicrobial drugs
Review
Accepted on 28 Nov 2025
in Biophotonics
Original Research
Accepted on 28 Nov 2025
in Immunogenetics
Original Research
Accepted on 28 Nov 2025
in Implementation Science
Original Research
Accepted on 28 Nov 2025
in Clinical Research in Nephrology
Original Research
Accepted on 28 Nov 2025
in Geohazards and Georisks
Original Research
Accepted on 28 Nov 2025
in Mechanisms in Allergy
Original Research
Accepted on 28 Nov 2025
in Artificial Intelligence in Radiology